Keywords
rectal atresia - children - surgical intervention - pull-through procedure - posterior
sagittal anorectoplasty
Introduction
Anorectal malformations (ARM) occur in approximately 1 per 5,000 live births each
year.[1] An extremely rare entity amongst ARM is rectal atresia (RA), representing approximately
1to 2% of all ARM[1] and is, according to the Krickenbeck classification for ARM, therefore categorized
under the “rare” variants.[2]
[3] RA can be subdivided into five types with potentially heterogeneous disease morphology
and clinical presentation.[4] These five types of RA are as follows: type I: rectal stenosis, (A) intramural,
(B) web with a hole; type II: RA with a septal defect; type III: RA with a fibrous
cord between two atretic ends; type IV: RA with a gap; type V: multiple: (A) RA with
stenosis, (B) multiple RA, and (C) thickened Houston's valves/multiple rectal stenosis;
as illustrated by Sharma and Gupta[4]).
Children with RA require surgical treatment due to the clinical consequences of this
disease (e.g., inability to pass meconium, bowel distension, and potentially sepsis).
In most children, initially a diverting (sigmoid) colostomy is created as prompt surgical
intervention, after which at later stage, a definitive reconstructive intervention
is performed.[5] Definitive reconstruction in children with RA can be done using several different
surgical techniques. For example, local excision (e.g., opening the rectal web, stricturoplasty,
dilation, and perforation), anorectoplasty (dissecting posterior sphincter complex
or both posterior and anterior), pull-through surgery (e.g., transanal endorectal
pull-through [similar to surgical treatment for Hirschsprung's disease (HD)][6]), abdominoperineal pull-through, sphincter saving pull-through), and other innovative
treatment options (e.g., magnamosis).[7] Some techniques are rarely used and relatively new, such as magnamosis, a treatment
strategy that involves the use of two magnets to create an anorectal anastomosis (previously
described as treatment for esophageal atresia[8]). However, no consensus has yet been reached on the optimal treatment strategy because
different RA types may necessitate different treatment strategies or surgical approaches.
Due to the rarity of RA and its heterogeneous presentation, lack of clarity exists
on what the optimal treatment strategy and their outcomes is. Case reports and series
describing techniques for treatment of RA have been published. Yet, the current literature
lacks a systematic review. Therefore, the aim of this systematic review is to provide
an overview of the surgical interventions used for RA and their outcomes in the current
available literature.
Materials and Methods
Study Design
A systematic review was performed according to the Preferred Reporting Items for Systematic
Reviews and Meta-analyses (PRISMA) statement guidelines ([Supplementary Table A1], available in the online version only).[9] This review has been registered at the International Prospective Register of Systematic
Reviews (PROSPERO, registration number: 309464).
Literature Search
A systematic literature search was performed in PubMed (Medline), Embase.com (Ovid),
Clarivate Analytics/Web of Science Core Collection, and the Wiley/Cochrane Library.
The timeframe within the databases was from inception to January 24, 2022. The search
strategy was developed in collaboration with a clinical librarian (G.L.B.). The search
included keywords and free text terms for (synonyms of) “Rectal Atresia” OR “Anorectal
malformation,” combined with (synonyms of) “Pull-through” OR “Surgery.” Studies were
also cross-referenced for additional articles. A full overview of the search terms
per database can be found in the [Supplementary Table A2] (available in the online version only).
Eligibility Criteria
Studies were included if they described the surgical treatment for RA in the pediatric
population (< 18 years of age) or if the data on RA could be separately extracted
from any other population described in the article. Randomized controlled trials (RCT's),
retrospective or prospective cohort studies, case series, and case reports were eligible
for inclusion. Studies were excluded if they described other types of rare ARM or
ARM in general, prenatal/fetal surgical treatment of RA, or adults who had surgical
correction of RA in childhood, if they were published before January 1, 2000, or in
languages other than English or Dutch, if studies were unpublished or only abstract
were available.
Study Selection and Methodological Quality Assessment
After duplicate removal, two reviewers (S.R.J.B. and C.M.C.B.) independently screened
all titles and abstracts using Rayyan.[10] Studies were obtained in full-text and further selected based on full text. In case,
articles were not available in full text, authors were contacted. In case of disagreement
between reviewers, a third reviewer (R.R.G.) was consulted for final decision.
Two independent reviewers (S.R.J.B. and C.M.C.B.) assessed methodological quality,
using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Case reports
and Case series.[11]
[12] For case reports, this tool comprises eight questions regarding methodological quality
with four answer options (“Yes,” “Unclear,” “Not applicable,” or “No”; [Supplementary Document 1] [available in the online version only]). Each answer option was quantified by assigning
a score of 3, 2, 1, or 0, respectively. Scores were summed, with a maximum of 24 points
for each case report. “High” quality was defined as 19 points or higher, “Moderate”
as 14 to 18 points, and “Low” defined as 13 points or fewer. For case series, this
tool comprises 10 questions regarding methodological quality with the four answer
options ([Supplementary Document 2], available in the online version only). A maximum score of 30 could be assigned.
“High” quality was defined as 24 or higher, “Moderate” as 17 to 23, and “Low” as 16
or fewer. In case of cohort studies, methodological quality was assessed by using
the Newcastle–Ottawa Scale (NOS).[13] In case of disagreement, a third reviewer (R.R.G.) was consulted for final decision.
Data Extraction
Data on identification features of the study, study characteristics, participant characteristics,
associated anomalies (i.e., cardial, tracheoesophageal, and urological anomalies;
presacral mass; spinal anomalies; and tethered cord), type of RA (defined as reported
by the original study), type of surgical intervention, and results were extracted
by two independent reviewers (S.R.J.B. and C.M.C.B.) according to predefined data
collection forms from all included studies. Definitive surgical intervention was categorized
into four main treatment groups (i.e., PSARP (posterior sphincter complex dissected
or both posterior and anterior), pull-though (i.e., transanal, abdominoperineal, laparoscopic
assisted, and sphincter saving), local excision (i.e., transanal, stricturoplasty,
opening rectal web, and endoscopic) and other (i.e., magnamosis). In case of uncertainties,
a third reviewer (R.R.G.) was consulted for final decision.
Outcomes
Primary outcomes were the number of surgical interventions and the number of postoperative
complications after definitive operation technique (i.e., postoperative complications
within 30 days [defined as reported by the original study (i.e., anal or rectal stricture,
wound infection, wound dehiscence, and rectal prolapse)]). Secondary outcomes were
severity of complications according to Clavien–Dindo grading[14] and functional outcomes at follow-up with time points as reported by the original
study (i.e., constipation, soiling, urinary continence, voiding difficulties, and
sexual development) and quality of life. Functional bowel outcomes (e.g., voluntary
bowel movements, soiling, and constipation) were assessed according to the Holschneider
continence score.[15] If postoperative complications or functional outcomes were not explicitly described
in the original study, it was categorized as not present, and authors were contacted
for missing data. If additional information was provided, it was incorporated in the
results section. If additional data were not provided, it was categorized as missing
data.
Statistical Analysis
Descriptive statistics were used for analysis of baseline, disease, and treatment
characteristics. These were reported as proportions for binary or categorical variables.
Missing or unknown data were described. No comparisons, quantitative syntheses, or
meta-analyses were performed due to the expected small numbers and large heterogeneity.
Results
Study Selection
In total, 6,716 studies were identified through searching PubMed (n = 1,779), Embase (n = 3,568), Web of Science (n = 1,363), and Cochrane Library (n = 6). After duplicate removal, the remaining 4,127 studies were screened on title
and abstract. Ninety-nine studies were eligible for full-text assessment of which
22 were included in this systematic review. In nine studies, full text was not available
and authors were contacted of whom none responded. The PRISMA flowchart of study selection
with reasons for exclusion is shown in [Fig. 1].
Fig. 1 PRISMA 2020 flow diagram. PRISMA, Preferred Reporting Items for Systematic Reviews
and Meta-analyses.
In total, 77 studies were excluded of which the following of interest: four studies
with reason “surgical intervention unclear” as RA was solely mentioned in the study
without describing surgical treatment.[2]
[16]
[17]
[18] Furthermore, three studies were excluded based on “different population” due to
adult patient in one study[19] and data on RA not separately extractable from the ARM population in two studies.[20]
[21] Finally, one study was excluded with reason “other disease entity,” due to RA occurring
after necrotizing enterocolitis (NEC),[22] and one study with reason “fetal intervention” due to RA correction in utero.[23]
Study Characteristics
In total, four case series and 18 case reports were included, comprising a total of
70 patients with RA (37 males, 21 females, and 12 unknown[4]
[5]
[7]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
[32]
[33]
[34]
[35]
[36]
[37]
[38]
[39]
[40]
[41]
[42]). Age at definitive surgical correction ranged from 1 day (after full-term gestational
age) to 6 years of age. [Table 1] shows characteristics of the 22 included studies and their included patients. None
of the included studies have used the classification of RA by Sharma and Gupta,[4] since the introduction in 2017. Unfortunately, due to the unclear reporting of RA
definition, classification accordingly was not possible. Various definitions of RA
have been used by the included studies as depicted in [Supplementary Table A3] (available in the online version only).
Table 1
General characteristics of included studies and patients
Study
|
Year
|
Country
|
Study design
|
Number of patients
|
Sex
|
Age at definitive surgery
|
Surgical technique
|
Follow-up
|
Ahn et al[24]
|
2019
|
The United States
|
Case report
|
1
|
M
|
11 months
|
Pull-through
|
2 months
|
Gieballa et al[5]
|
2018
|
Saudi Arabia
|
Case report
|
3
|
M
|
6–10 months
|
Pull-through (n = 3)
|
4 years
|
4 years
|
4 years
|
Mehmetoğlu[25]
|
2018
|
Turkey
|
Case report
|
1
|
M
|
9 months
|
PSARP[a]
|
4,5 years
|
Sharma and Gupta[4]
|
2017
|
India
|
Case series
|
10
|
7 M, 3 F
|
Unknown
|
PSARP[d] (n = 4),
Pull-through (n = 2), Local excision (n = 4)
|
3 years
|
Braiek et al[26]
|
2016
|
Tunisia
|
Case report
|
1
|
M
|
2 days
|
Local excision
|
6 months
|
Lane et al[27]
|
2016
|
The United States
|
Case report
|
1
|
M
|
10 months
|
PSARP[a]
|
Unknown
|
Eltayeb and Shehata[28]
|
2015
|
Egypt
|
Case series
|
2
|
1 M, 1 F
|
8–9 months
|
Pull-through (n = 2)
|
18 months
|
18 months
|
Laamrani and Dafiri[29]
|
2014
|
Morocco
|
Case report
|
1
|
F
|
20 days
|
PSARP[b]
|
Unknown
|
Russell et al[7]
|
2014
|
The United States
|
Case report
|
1
|
M
|
4 months
|
Magnamosis
|
4 years
|
Hamrick et al[30]
|
2012
|
The United States
|
Case series
|
17
|
10 M, 7 F
|
2 days–6 years
|
PSARP[a] (n = 17)
|
4 years
|
Hamzaoui et al[31]
|
2012
|
Tunisia
|
Case report
|
1
|
F
|
6 months
|
Pull-through
|
2 years
|
Stenström et al[32]
|
2011
|
Sweden
|
Case report
|
1
|
F
|
4 months
|
Local excision
|
3 months
|
Hosseini et al[33]
|
2009
|
Iran
|
Case report
|
1
|
F
|
2 years
|
Pull-through
|
Unknown
|
Luo et al[34]
|
2009
|
Taiwan
|
Case report
|
3
|
F
|
3–6 months
|
PSARP[b] (n = 1),
Pull-through (n = 2)
|
3 years
|
1 year
|
3 months
|
Lee et al[35]
|
2007
|
China
|
Case report
|
1
|
M
|
5 months
|
PSARP[b]
|
2 years
|
Nguyen and Pham[36]
|
2007
|
Vietnam
|
Case report
|
2
|
F
|
3 months
|
Pull-through (n = 2)
|
8 months
|
5 months
|
Ibrahim[37]
|
2006
|
Egypt
|
Case report
|
4
|
3 M, 1 F
|
1–5 days
|
Pull-through (n = 4)
|
Unknown
|
Unknown
|
Unknown
|
Not applicable[e]
|
Kisra et al[38]
|
2005
|
Morocco
|
Case report
|
4
|
M
|
3 months
|
PSARP[b] (n = 4)
|
Unknown
|
Unknown
|
11 years
|
15 years
|
Kobayashi et al[39]
|
2005
|
Japan
|
Case report
|
1
|
M
|
4 months
|
PSARP[b]
|
5 years
|
Belizon et al[40]
|
2005
|
The United States
|
Case series
|
12
|
Unknown
|
Unknown
|
PSARP[d]
|
Unknown
|
Saxena et al[41]
|
2004
|
Germany
|
Case report
|
1
|
M
|
1 day
|
Local excision
|
Unknown
|
Ramesh et al[42]
|
2002
|
Malaysia
|
Case report
|
1
|
M
|
4 weeks
|
PSARP[d]
|
9 months
|
Abbreviations: F, female; M, male; PSARP, posterior sagittal anorectoplasty.
a Posterior sphincter opened
b Posterior and anterior sphincter opened.
c Anterior sphincter opened.
d Sphincter opening not mentioned.
e Not applicable because of death due to pulmonary complication.
Methodological Quality
According to the JBI Critical Appraisal Checklist, 10 of 18 case reports were of high
quality with a score of 19 or greater.[5]
[7]
[32]
[33]
[34]
[36]
[37]
[38]
[41]
[42] The remaining 8 of 18 were of moderate quality with scores ranging from 16 to 18.[24]
[25]
[26]
[27]
[29]
[31]
[35]
[39] Moderate scores were mostly due to lack of description of adverse or unanticipated
events and no provision of takeaway lessons. Of the case series, two of four studies
were of high quality with scores of 25 and 28, respectively.[4]
[30] The other two of four studies were of moderate quality with scores of 20 and 22,
respectively.[28]
[40] No studies were of low quality. An overview of individual methodological quality
assessment of included studies is provided as [Supplementary Table A4] (available in the online version only).
Definitive Operation Technique and Number of Postoperative Complications
In general, 16 of 22 studies reported postoperative follow-up less than 30 days for
(some) included patients, comprising 56 of 70 patients. In 4 of 56 patients, a postoperative
complication was noted (i.e., anal stenosis [n = 1], anastomotic stenosis [n = 2], and death [n = 1]).[4]
[5]
[7]
[24]
[25]
[26]
[28]
[30]
[32]
[34]
[36]
[37]
[38]
[39]
[40]
[41] Clavien–Dindo scores per postoperative complication are shown in [Table 2].
Table 2
Treatment options and postoperative complications
Surgical intervention
|
Number of patients
|
Reporting follow-up < 30 days[a]
n (%)
|
Postoperative complications[b]
|
Classification[c]
|
Number of studies
|
Posterior sagittal anorectoplasty
|
43
|
37 (86.0)
|
Anal stenosis (n = 1)[30]
Anastomotic stenosis (n = 2)[38]
|
IIIa
IIIa
|
10[4]
[25]
[27]
[29]
[30]
[34]
[35]
[38]
[39]
[40]
|
Pull-through
|
Transanal
|
10
|
5 (50.0)
|
Death (n = 1)[37]
|
V
|
4[5]
[31]
[34]
[37]
|
Laparoscopic assisted
|
3
|
2 (66.7)
|
–
|
–
|
2[24]
[36]
|
Abdominoperineal
|
3
|
2 (66.7)
|
–
|
–
|
2[4]
[33]
|
Sphincter saving
|
2
|
2 (100.0)
|
–
|
–
|
1[28]
|
Local excision
|
Transanal
|
4
|
4 (100.0)
|
–
|
–
|
2[4]
[41]
|
Opening rectal web
|
2
|
1 (50.0)
|
–
|
–
|
2[26]
[42]
|
Stricturoplasty
|
1
|
1 (100.0)
|
–
|
–
|
1[4]
|
Endoscopic
|
1
|
1 (100.0)
|
–
|
–
|
1[32]
|
Other
|
Magnamosis
|
1
|
1 (100.0)
|
–
|
–
|
1[7]
|
a Number of patients with adequate reporting of follow-up < 30 days.
b Postoperative complication < 30 days.
c Classification according to Clavien–Dindo guidelines for postoperative surgical complications.[14]
In total, four main groups of treatment strategy were reported of which PSARP and
pull-through approach were performed most often in 43 of 70 patients and 18 of 70
patients, respectively ([Table 2]).
Regarding PSARP (n = 43), data on postoperative complications were present in 38 patients of whom 3
experienced a postoperative complications (i.e., two anastomotic stenosis which required
dilatation for 3 months and one anal stenosis requiring dilatations; [Table 2]).[30]
[38]
Regarding pull-through surgery (transanal, laparoscopic assisted pull-through, abdominoperineal
pull-through, and sphincter saving pull-through surgery, n = 18), data on postoperative complications were present in 11 patients of whom 1
experienced a postoperative complication after transanal pull-through surgery (death
due to clinical deterioration and pulmonary complications; [Table 2]).[37] No other postoperative complications occurred.
Regarding local excision (i.e., transanal, opening rectal web, stricturoplasty, or
endoscopic, n = 8), data on postoperative complications were present in seven patients of whom
none experienced postoperative complications. Regarding magnamosis (n = 1), no postoperative complications occurred at follow-up of less than 30 days.
Details of the used operative techniques and their postoperative complications (according
to Clavien-Dindo) are demonstrated in [Table 2]. Further specification of used operative technique (e.g., dissection of sphincter
complex and preservation of anal canal) is shown in [Supplementary Table A3] (available in the online version only).
Definitive Operation Technique and Functional Outcomes
In general, 18 of 22 studies reported functional outcomes for (some) included patients,
comprising 52 of 70 patients.[4]
[5]
[7]
[24]
[25]
[26]
[28]
[30]
[31]
[32]
[34]
[35]
[36]
[37]
[38]
[39]
[41]
[42] For bowel and urinary function, follow-up ranged from 2 months to 15 years after
definitive correction of RA ([Table 1]). However, timing of follow-up was not mentioned in three studies, comprising four
patients.[37]
[38]
[41]
Regarding PSARP (n = 43), data on functional outcomes were available for 28 of 43 patients, regarding
constipation/soiling. Constipation (grade IIA, requiring laxative treatment) occurred
in six of them (at follow up 48–54 months).[25]
[30] The remaining follow-up in other studies ranged from 9 months to 5 years ([Table 1]). Occasional soiling occurred in one patient (at 3-year follow-up).[34] The remaining 21 patients had daily stool and voluntary bowel movements (grade I).
No studies describing PSARP reported data on functional urinary outcomes.
Regarding pull-through surgery (n = 18), data on functional outcomes were available for 15 of 18 patients regarding
constipation/soiling, and for 1 of 18 patients regarding urinary outcomes. In total,
5 of 15 patients developed constipation (grade IIA) (three after transanal pull-through,
one after abdominoperineal pull-through, and one after sphincter saving pull-through)
at, respectively, 18 months, 3, and 4 years of follow-up.[4]
[5]
[28] No soiling was reported. One case was found to have neurogenic bladder disorder
after presenting at 1 year follow-up with a febrile urinary tract infection and grade
II vesicoureteral reflux bilaterally, requiring clean intermittent catheterization
(CIC) and prophylactic antibiotics up until he reached the age of 12 years.[5]
Regarding local excision (n = 8), data on functional outcomes were available for 8 of 8 patients of whom all
had normal bowel function at follow-up ranging from 3 months to 3 years. No data on
urinary outcomes were reported.
The one patient that underwent magnamosis had normal bowel function at 4 years of
follow-up.[7] No data on urinary outcomes were reported.
Sexual Development and Quality of Life
No studies reported data on sexual development or quality of life at follow-up.
Diversion Colostomy
The use of a diverting (sigmoid) colostomy was reported for 56 of 70 patients of whom
45 of 56 had a (sigmoid) colostomy. Timing on colostomy placement differed between
directly at presentation (after birth; 17/45) or during definitive RA correction (28/45).
Different types of colostomy were performed (e.g., left transverse loop colostomy,
right transverse loop colostomy, double barrel sigmoid colostomy, and sigmoid colostomy).
Colostomy was temporary in all patients as all patients underwent definitive surgical
correction of RA.
Associated Anomalies
In 45 of 70 patients, it was reported whether associated anomalies were present and
in 6 of 45 anomalies were identified. Regarding patients who underwent PSARP, 4 of
43 had associated anomalies (i.e., balanic hypospadias [n = 1], ectopic kidney [n = 1], tracheoesophageal fistula [n = 1], and bilateral nonpalpable cryptorchidism [n = 1]).[4]
[30]
[38] Regarding patients who underwent (transanal) pull-through, 1 of 18 had congenital
heart disease, minor omphalocele, hypospadias, and undescended testes.[5] Regarding patients who underwent (transanal) local excision, one of eight had a
congenital heart disease.[41] In 30 of 70 patients, it was reported whether presacral mass was present and in
8 of 30 presacral mass was identified of whom all underwent resection during their
definitive operation (PSARP).[30]
Discussion
RA is extremely rare and little is known about the different treatment options. This
systematic review of the available literature showed that only low-quality data (case
series and case reports) are available, with the majority of patients (61/70) undergoing
either posterior sagittal or pull-through approach. Postoperative follow-up of less
than 30 days was reported in 38 of 43 patients for PSARP and in 11 of 18 patients
for pull-through, and postoperative complications occurred in 3 of 38 patients and
1of 11 patients, respectively. Functional outcomes were reported in 28 of 43 patients
for PSARP and 15 of 18 patients for pull-through, with constipation in 6 of 28 patients
and 5 of 15 patients, respectively.
This study found data reported on postoperative complications in 57 of 70 patients,
with postoperative complications occurring in 4 of 57 patients. A previous systematic
review, comparing laparoscopic assisted anorectal pull-through (LAARP) and PSARP in
children with high and intermediate ARM, found a higher overall complication rate
of 28% (23% for LAARP and 33% for PSARP) with a slight lower reporting rate of 60%.[43] Unfortunately, in contrast to our study, postoperative complications were not further
specified. In our study, postoperative complications can be underreported in the included
studies as follow-up of less than 30 days was not reported in 13 of 70 patients. In
addition, one study[40] only reported on rectal prolapse and did not mention if other possible postoperative
complications were investigated. This registration and reporting bias likely leads
to an underestimation of postoperative complications and therefore a too positive
view of the outcomes in this cohort. The same goes for functional outcomes, as one-fifth
of the studies did not report this. In addition, data on bowel continence were missing
in a quarter of the patients, data on urinary outcomes were only reported in 1 of
70 patients, and no data on sexual development and quality of life were reported.
This could be partially explained by the fact that most included studies had a follow-up
of 4 years or lesser and included children (≤ 5 years of age) who might not yet be
potty-trained or are sexually active. Urinary and quality of life outcomes might be
difficult to assess in the early follow-up. These data demonstrate the importance,
especially in research for rare diseases, of (future studies with) uniformity and
adequate definitions and reporting of postoperative complications and functional outcomes.
Clear core outcome set developed in conjunction with the entire multidisciplinary
team and patient representatives might be the solution.
Children with RA most often have a normal positioned anus, with an atretic segment
approximately 2 cm above the dentate line. On one hand, by using pull-through technique,
the sphincter complex on the posterior side remains unaffected and intact with minimal
scarring of healthy tissue as a result. However, in the presence of a presacral mass,
pull-through surgery cannot be performed because of this anatomical variation. On
the other hand, PSARP (dissecting the posterior side or the complete sphincter [posterior
as well as anterior side]) may be preferred, as pull-through surgery (e.g., such as
in HD) can lead to soiling or fecal incontinence due to overstretching the sphincter
complex. In addition, in case of a long atretic segment, the urethra or vagina could
be at risk for damage during surgery. A meta-analysis on postoperative outcomes in
HD after transanal endorectal pull-through showed that the mean incidence of constipation
was 9.0% of incontinence or soiling was 6.3%, and of anastomotic stricture was 11%,
with duration of follow-up ranging from 12 to 60.5 months.[44] In our study, this was 33.3, 0.0, and 0.0%, respectively, with duration of follow-up
ranging from two to 180 months. These differences may be caused by different disease
etiology between HD and RA, heterogeneous patient groups, various procedures in our
population (i.e., not only pull-through techniques), and registration and publication
bias. Four different treatment strategies (PSARP, pull-through, local excision, and
other) were described in studies published from 2000 onwards of which PSARP and pull-through
techniques were the majority. Within the four main treatment strategy groups, large
heterogeneity in surgical technique was found. For example, in the PSARP group, in
some patients, only the posterior side of the sphincter complex was dissected, as
in others the complete sphincter complex was dissected (posterior and anterior; as
depicted in [Supplementary Table A3], available in the online version only). Furthermore, the study by Ramesh et al described
a patient in which PSARP approach was intended, but finally a local resection was
performed, emphasizing the added value of digital examination preoperatively.[42] Unfortunately, to date, still no consensus is reached as to what technique is most
preferred. However, not only operative technique but also comorbidity and potentially
associated anomalies or syndromes (e.g., presacral mass in Currarino's syndrome) are
of great importance to take into account in choosing the type of surgery. Finally,
it is important to choose a technique that fits within the expertise of the surgical
team. Therefore, uniform recommendation in this extremely rare disease might not be
possible, rather the entire multidisciplinary should outweigh the benefits of each
surgical procedure for the individual patient each time taken into account patient-related,
doctors-related, and hospital-related factors.
Some techniques are rarely used and are newer, such as magnamosis. Russell et al investigated
the use of magnamosis as treatment option for RA describing one patient. Results were
promising as no postoperative complications and good functional outcomes were found
at follow-up at 4 years in this single patient.[7] This treatment option has been described previously for other congenital malformations,
such as esophageal atresia, with varying results.[8]
[45] Therefore, results should be cautiously interpreted and extrapolated, and the technique
should be further assessed as little evidence is available.
In this study, almost 80% of the studies were performed after 2005 which was the year
of the publication of the Krickenbeck classification[2] in which RA is classified under “rare-variants” of ARM. In addition, guidelines
on RA definitions have been present in literature since 2006,[3] with an update in 2017 depicting a clear differentiation into five types of RA.[4] Still, large heterogeneity was found in RA definitions and, in almost half of the
patients, RA was mentioned without further classification or adequate description.[28]
[30]
[37]
[40] Only 14% of the studies were published since the latest 2017 update of which only
one study reported an adequate definition.[24] It is important to improve adequate registration, as this is a key to correct interpretation
of data and outcomes.
Strengths and Limitations
Strengths and Limitations
This study should be interpreted in light of some strengths and limitations. First,
due to a broad search, the risk of missing studies is low. However, to show most current
practice, all studies published before January 1, 2000, were excluded, potentially
leading to publication bias. In addition, nine authors did not respond to the request
for the full text of included studies after title and abstract screening. Furthermore,
underreporting of postoperative complications and functional outcomes was present
in 27 and 18% of the studies, respectively. Second, solely level IV of evidence studies
(i.e., case reports and series) with a small sample size, large heterogeneity (e.g.,
in patients, procedures, and definitions), and a lot of missing data were included
in this study. This hampered the possibility of performing statistical comparisons
or a meta-analysis. In addition, no hard conclusions could be drawn. Furthermore,
due to the inclusion of solely case reports and series, overall evidence of this systematic
review is low. However, all included case reports and series in itself were of moderate
to high quality ([Supplementary Table A4], available in the online version only). Third, almost all studies had a retrospective
character leading to inevitable selection and potential information bias. This, however,
is the first systematic review on treatment strategies for children with RA that shines
light on the various treatment options, but also on the lack of adequate use of definitions
and uniform reporting. This is important to identify the optimal treatment strategy
for the different types of RA.
Future research into most optimal treatment strategy for RA is necessary. Due to the
rare nature of RA, studies investigating this topic entail mostly low levels of evidence.
Therefore, most importantly, international centers should collaborate to gain a larger
cohort of RA patients and potentially create a Delphi's meeting. Prior to that, uniform
definitions of RA should be accepted and core outcome set should be developed (including
definitions and optimal measuring instrument for certain (functional) outcomes).
Conclusion
RA is extremely rare and little is known of the different treatment options. The majority
(61/70) of patients reported by the included studies was treated with posterior sagittal
or pull-through approach. Little was reported on postoperative complications and functional
outcomes at follow-up. Large heterogeneity in surgical techniques and definitions
op RA was found. Therefore, no definitive suggestions can be made for the most optimal
treatment option for RA but (dis)advantages of the surgical techniques should be outweighed
for each individual patient. More importantly, larger cohort studies should be performed
to assess the most optimal treatment strategy for children with RA, taking into account
accurate reporting of RA type, surgical intervention, postoperative complications,
and long-term outcomes.